InSite Vision Incorporated (OTCBB:INSV) announced that it has filed an Investigational New Drug (IND) application for ISV-101 with the U.S. Food and Drug Administration (FDA). ISV-101 is InSite Vision’s novel compound being developed to treat dry eye d…
Study Sheds New Light On River Blindness Parasite
The team found that a bacterium inside the worm acts as a ‘disguise’ for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body’s natural defences, but once the bacteria are remov…
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
Status: Not yet recruiting,
Condition Summary: Glaucoma; Ocular Hypertension
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
Status: Completed,
Condition Summary: Dry Eye Disease
New Year, New Vision, New Health
VISTAKON®, Division of Johnson & Johnson Vision Care, Inc., and makers of ACUVUE® Brand Contact Lenses today announced the “New You” sweepstakes to give consumers the chance to have improved vision and better fitness in the New Year.
Scientific Evidence Supports Effectiveness Of Chinese Drug For Cataracts
Scientists are reporting a scientific basis for the long-standing belief that a widely used non-prescription drug in China and certain other countries can prevent and treat cataracts, a clouding of the lens of the eye that is a leading cause of vision …